•
Dec 31, 2020

Seres Therapeutics Q4 2020 Earnings Report

Total Revenue
$17.6M
Previous year: $7.62M
+130.4%
EPS
-$0.19
Previous year: -$0.25
-24.0%
Gross Profit
-$7.3M
Cash and Equivalents
$116M
Free Cash Flow
-$18.2M
Total Assets
$343M

Seres Therapeutics

Seres Therapeutics